A few nights ago I found myself in an interesting situation - I was at Matt Gonzalez birthday party at his home and the traditional “what do you do for a living” question came up in a conversation circle. For those who don’t know Matt, he is an American liberal politician, lawyer and activist, prominent in San Francisco politics and also the vice presidential candidate for Ralph Nader. The people in the circle were either activists or artists, and when I said that I worked in marketing for the life sciences industry there was no shortage of reproachful looks and one brave man who asked me in a disapproving tone ‘do you mean you work for the pharmaceutical industry?’.
Tags: Personalized Medicine, Product Strategy, Global Strategy
Earlier this month Senator Edward Kennedy heard testimony from leading cancer advocates in a hearing titled Cancer: Challenges and Opportunities in the 21st Century. Greg Simon, President of FasterCures was one of the panel witnesses on May 8th and this week had the following to say on hearing the news of Senator Kennedy’s own diagnosis with a malignant brain tumor this week.
Tags: Oncology, Product Strategy, Patient Strategy
In the early part of this decade, the design and usability community was actively engaged in a discussion of how to make the Internet more accessible to those with vision or cognitive disabilities. User interface expert Jakob Nielsen published a fairly detailed report on the topic in 2001 and the WC3, the organization that governs the standards of website development, formed the Web Content Accessibility Guidelines Working Group. There was also very spirited criticism and discussion of the above published by Jeffrey Zeldman, editor of the web development and usability online journal, A List Apart.
Tags: Accessibility, Usability, Patient Strategy, Product Strategy, Investor Strategy, Transforming Technology
The topic of speeding up websites deployed using the Drupal content management system is a well traveled and rich literary landscape. In fact, search the internet for a variety of performance topics, both Drupal specific and more generic and you will find dozens of articles offering advice, techniques and all too often sympathy for your plight. Unfortunately, the wealth of conversation on the topic is a pretty good indication of the need to get information about making Drupal perform.
Tags: Transforming Technology, Patient Strategy, Product Strategy, Global Strategy
I am the CEO of a communications agency that depends directly on DTC and DTP advertising for a significant portion of our bottom line. One of our largest clients is a non-profit patient advocacy group. In addition, we have many, many clients who have to balance their passion for finding cures with their need to satisfy their investors' expectations. As we begin 2008 and listen to the Presidential candidates views on healthcare, we hear a lot of strident voices within industry often pitted against patient advocacy. It seems that there's a lot of talk about change, a lot of serious resistance to change, and a lot of skeptics who say the pharmaceutical industry will never change.